Despite Biden’s nod, don’t hold your breath for a vaccine IP waiver

Months of WTO talks lie ahead, with drug firms and governments fighting to keep waiver as narrow as possible

06 May 2021 - 20:53 By David Lawder

Now that US President Joe Biden has backed a proposed waiver for Covid-19 vaccine intellectual property rights, the next stop is for the World Trade Organization to hammer out a deal — a process that could take months.

Not only are the negotiations expected to be lengthy, they are also likely to result in a waiver that is significantly narrower in scope and shorter in duration than the one initially proposed by India and SA, trade experts said...

This article is free to read if you register or sign in.

If you have already registered or subscribed, please sign in to continue.

Questions or problems? Email or call 0860 52 52 00.